We are live on
!
Find out more
FAT
First American Trust Portfolio holdings
AUM
$1.49B
1-Year Est. Return
21.98%
This Fund
S&P 500
This Quarter
Est. Return
+3.22%
1 Year Est. Return
+21.98%
3 Year Est. Return
+75.41%
5 Year Est. Return
+98.06%
10 Year Est. Return
+373.27%
AUM
$359M
AUM Growth
+$31.5M
(+9.6%)
Cap. Flow
+$23.2M
Cap. Flow
% of AUM
6.46%
Top 10 Holdings %
Top 10 Hldgs %
30.7%
Holding
120
New
13
Increased
52
Reduced
33
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLGX
Corelogic, Inc.
CLGX
|
+$10.8M |
| 2 |
Incyte
INCY
|
+$4.82M |
| 3 |
Starbucks
SBUX
|
+$3.76M |
| 4 |
PX
Praxair Inc
PX
|
+$3.07M |
| 5 |
Sempra
SRE
|
+$2.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Mosaic Company
MOS
|
+$3.7M |
| 2 |
Amgen
AMGN
|
+$2.78M |
| 3 |
GE Aerospace
GE
|
+$2.57M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$2.15M |
| 5 |
Pfizer
PFE
|
+$2.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.32% |
| 2 | Financials | 12.29% |
| 3 | Consumer Discretionary | 9.27% |
| 4 | Technology | 8.36% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
DuPont de Nemours
DD
$18.6B
| $869K | 0.24% |
5,442
| – | – |
|
77
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $777K | 0.22% |
3,212
+546
| +20% | +$131K |
|
78
Invesco S&P 500 Low Volatility ETF
SPLV
$7.2B
| $747K | 0.21% |
16,701
+948
| +6% | +$42K |
|
|
PIV
79
DELISTED
PWSHS S&P 500 HIGH QTY PORTF S&P HIGH QTY RKGS INDEX
PIV
| $738K | 0.21% |
26,402
+2,167
| +9% | +$60.6K |
|
80
Zimmer Biomet
ZBH
$17.7B
| $648K | 0.18% |
5,195
| – | – |
|
81
Johnson & Johnson
JNJ
$635B
| $581K | 0.16% |
4,394
-2,052
| -32% | -$262K |
|
82
CVS Health
CVS
$137B
| $542K | 0.15% |
6,738
-54
| -0.8% | -$4.26K |
|
83
Quest Diagnostics
DGX
$25.1B
| $489K | 0.14% |
4,395
+14
| +0.3% | +$1.48K |
|
84
iShares MSCI EAFE ETF
EFA
$76.4B
| $425K | 0.12% |
6,520
-36
| -0.5% | -$2.33K |
|
85
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
| $403K | 0.11% |
3,224
+264
| +9% | +$32.6K |
|
86
Intel
INTC
$466B
| $366K | 0.1% |
10,870
+1,600
| +17% | +$57.3K |
|
87
Novartis
NVS
$295B
| $366K | 0.1% |
4,893
| – | – |
|
88
Philip Morris
PM
$301B
| $364K | 0.1% |
3,100
| – | – |
|
89
AbbVie
ABBV
$458B
| $349K | 0.1% |
4,821
+1,300
| +37% | +$87.4K |
|
90
Altria Group
MO
$122B
| $341K | 0.09% |
4,580
| – | – |
|
91
iShares Russell Mid-Cap ETF
IWR
$56.8B
| $321K | 0.09% |
6,688
-4
| -0.1% | -$190 |
|
92
iShares MBS ETF
MBB
$39B
| $299K | 0.08% |
2,805
+804
| +40% | +$86K |
|
|
BSJH
93
DELISTED
Guggenheim BulletShares 2017 High Yield Corporate Bond ETF
BSJH
| $278K | 0.08% |
10,803
| – | – |
|
94
Verizon
VZ
$194B
| $269K | 0.07% |
6,016
+1,100
| +22% | +$51.2K |
|
95
iShares Russell 1000 Value ETF
IWD
$82B
| $262K | 0.07% |
+2,254
| New | +$259K |
|
|
BSJI
96
DELISTED
Invesco BulletShares 2018 High Yield Corporate Bond ETF
BSJI
| $254K | 0.07% |
10,004
| – | – |
|
|
97
Amgen
AMGN
$203B
| $243K | 0.07% |
1,413
-17,086
| -92% | -$2.78M |
|
98
Merck
MRK
$324B
| $242K | 0.07% |
+3,948
| New | +$240K |
|
99
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $238K | 0.07% |
+6,850
| New | +$236K |
|
100
3M
MMM
$89B
| $236K | 0.07% |
1,357
-108
| -7% | -$18.1K |
|
Similar funds
OA
AIA
LFS
PIM
NAM
RIM
SB
MCM
First American Trust's Q2 2017 Portfolio in Review
As of Q2 2017, First American Trust held 120 positions worth $359M, up 9.6% from $328M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
First American Trust deployed $23.2M of net new capital in Q2 2017, opening 13 new positions and adding to 52 existing holdings. Its largest new stake was Incyte: 37,870 shares worth $4.77M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Amgen, an estimated $2.78M trimmed.
- First American Trust's largest Q2 2017 buy was Incyte: 37,870 shares worth $4.77M.
- First American Trust added most to Corelogic, Inc. in Q2 2017, an estimated $10.8M increase.
- First American Trust's biggest Q2 2017 reduction was Amgen, cutting an estimated $2.78M.
- First American Trust fully exited The Mosaic Company in Q2 2017, selling an estimated $3.7M.
- First American Trust's ten largest holdings make up 31% of its $359M portfolio in Q2 2017.
- First American Trust opened 13 new positions and closed 10 in Q2 2017.
- First American Trust's portfolio value rose 9.6% quarter-over-quarter to $359M.
Based on First American Trust's 13F filing for Q2 2017, filed 6 Jul 2017.